OliX Pharmaceuticals, Inc (KOSDAQ:226950)
South Korea · Delayed Price · Currency is KRW 111,600
-2,600 (-2.28%)
Sep 18, 2026, 3:30 PM KST
OliX Pharmaceuticals Market Cap
OliX Pharmaceuticals has a market cap or net worth of 2.54 trillion as of September 18, 2026. Its market cap has increased by 54.56% in one year.
Market Cap
2.54T
Enterprise Value
2.35T
Revenue
13.64B
Ranking
n/a
PE Ratio
n/a
Stock Price
111,600.00
ChartMarket Cap Chart
Since July 18, 2018, OliX Pharmaceuticals's market cap has increased from 422.03B to 2.54T, an increase of 501.61%. That is a compound annual growth rate of 24.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 2.54T | -10.43% |
| Dec 30, 2025 | 2.83T | 697.30% |
| Dec 30, 2024 | 355.53B | 52.22% |
| Dec 28, 2023 | 233.57B | -16.24% |
| Dec 29, 2022 | 278.86B | -50.37% |
| Dec 30, 2021 | 561.83B | -17.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SK Biopharmaceuticals | 6.12T |
| HLB Co., Ltd. | 4.24T |
| Peptron | 3.42T |
| ABL Bio | 3.24T |
| LigaChem Biosciences | 3.08T |
| SK bioscience | 2.83T |
| Voronoi | 2.56T |
| Hugel | 2.50T |